SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Abraham G, Gottschalk J, Ungemach FR. 2005. Evidence for ototopical glucocorticoid-induced decrease in hypothalamic-pituitary-adrenal axis response and liver function. Endocrinology 146: 31633171.
  • Adams JC, Seed B, Lu N, Landry A, Xavier RJ. 2009. Selective activation of nuclear factor kappa B in the cochlea by sensory and inflammatory stress. Neuroscience 160: 530539.
  • Agrup C. 2008. Immune-mediated audiovestibular disorders in the paediatric population: a review. Int J Audiol 47: 560565.
  • Ahn JH, Yoo MH, Lee HJ, Chung JW, Yoon TH. 2010. Coenzyme Q10 in combination with steroid therapy for treatment of sudden sensorineural hearing loss: a controlled prospective study. Clin Otolaryngol 35: 486489.
  • Alexander TH, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulya AJ, Hammerschlag PE, Hannley M, Hughes GB, Moscicki R, Nelson RA, Niparko JK, Rauch SD, Telian SA, Brookhouser PE, Harris JP. 2009. Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease. Otol Neurotol 30: 443448.
  • Amor Dorado JC, Barreira Fernandez Mdel P, Regueiro Villarin S, Gonzalez-Gay MA. 2009. [Audiovestibular manifestations in systemic vasculitis]. Acta Otorrinolaringol Esp 60: 432442.
  • Andrews JC, Honrubia V. 2010. Premenstrual exacerbation of Meniere's disease revisited. Otolaryngol Clin North Am 43: 10291040.
  • Arnold WJ. 1987. Oto-immunology. Facts or fantasy? In: Veldman JE, editor. Immunobiology, histophysiology, tumor immunology in otorhinolaryngology. Amsterdam: Kugler Publications. p 3945.
  • Baek MJ, Park HM, Johnson JM, Altuntas CZ, Jane-Wit D, Jaini R, Solares CA, Thomas DM, Ball EJ, Robertson NG, Morton CC, Hughes GB, Tuohy VK. 2006. Increased frequencies of cochlin-specific T cells in patients with autoimmune sensorineural hearing loss. J Immunol 177: 42034210.
  • Bamberger CM, Schulte HM, Chrousos GP. 1996. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 17: 245261.
  • Beeson PB. 1994. Age and sex associations of 40 autoimmune diseases. Am J Med 96: 457462.
  • Brenner M, Hoistad DL, Hain TC. 2004. Prevalence of thyroid dysfunction in patients with Meniere's disease. Arch Otolaryngol Head Neck Surg 130: 226228.
  • Brookes GB. 1986. Circulating immune complexes in Meniere's disease. Arch Otolaryngol Head Neck Surg 112: 536540.
  • Buijs RM, van Eden CG, Goncharuk VD, Kalsbeek A. 2003. The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system. J Endocrinol 177: 1726.
  • Byl FM, Jr. 1984. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope 94: 647661.
  • Cadoni G, Fetoni AR, Agostino S, de Santis A, Manna R, Ottaviani F, Paludetti G. 2002. Autoimmunity in sudden sensorineural hearing loss: possible role of anti-endothelial cell autoantibodies. Acta Otolaryngol Suppl 548: 3033.
  • Canlon B, Meltser I, Johansson P, Tahera Y. 2007. Glucocorticoid receptors modulate auditory sensitivity to acoustic trauma. Hear Res 226: 6169.
  • Chang A, Eastwood H, Sly D, James D, Richardson R, O'Leary S. 2009. Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery. Hear Res 255: 6772.
  • Chaouloff F, Groc L. 2011. Temporal modulation of hippocampal excitatory transmission by corticosteroids and stress. Front Neuroendocrinol 32: 2542.
  • Chen Y, Wen L, Hu P, Qiu J, Lu L, Qiao L. 2010. Endoscopic intratympanic methylprednisolone injection for treatment of refractory sudden sensorineural hearing loss and one case in pregnancy. J Otolaryngol Head Neck Surg 39: 640645.
  • Claes J, van de Heyning PH. 2000. A review of medical treatment for Meniere's disease. Acta Otolaryngol Suppl 544: 3439.
  • Cogan DG. 1945. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol 33: 144149.
  • Conlin AE, Parnes LS. 2007a. Treatment of sudden sensorineural hearing loss. I. A systematic review. Arch Otolaryngol Head Neck Surg 133: 573581.
  • Conlin AE, Parnes LS. 2007b. Treatment of sudden sensorineural hearing loss. II. A Meta-analysis. Arch Otolaryngol Head Neck Surg 133: 582586.
  • Couloigner V, Sterkers O, Ferrary E. 2006. What's new in ion transports in the cochlea? Pflugers Arch 453: 1122.
  • Datson NA, Morsink MC, Meijer OC, de Kloet ER. 2008. Central corticosteroid actions: search for gene targets. Eur J Pharmacol 583: 272289.
  • de Kloet ER, Reul JM. 1987. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 12: 83105.
  • de Kloet ER, Sutanto W, Rots N, van Haarst A, van den Berg D, Oitzl M, van Eekelen A, Voorhuis D. 1991. Plasticity and function of brain corticosteroid receptors during aging. Acta Endocrinol (Copenh) 125 ( Suppl 1): 6572.
  • Derebery MJ, Berliner KI. 2010. Allergy and its relation to Meniere's disease. Otolaryngol Clin North Am 43: 10471058.
  • Derebery MJ, Rao VS, Siglock TJ, Linthicum FH, Nelson RA. 1991. Meniere's disease: an immune complex-mediated illness? Laryngoscope 101: 225229.
  • Deroee AF, Huang TC, Morita N, Hojjati M. 2009. Sudden hearing loss as the presenting symptom of systemic sclerosis. Otol Neurotol 30: 277279.
  • Dornhoffer JL, Arenberg JG, Arenberg IK, Shambaugh GE, Jr. 1997. Pathophysiological mechanisms in immune inner ear disease. Acta Otolaryngol Suppl 526: 3036.
  • Doyle KJ, Bauch C, Battista R, Beatty C, Hughes GB, Mason J, Maw J, Musiek FL. 2004. Intratympanic steroid treatment: a review. Otol Neurotol 25: 10341039.
  • Evans KL, Baldwin DL, Bainbridge D, Morrison AW. 1988. Immune status in patients with Meniere's disease. Arch Otorhinolaryngol 245: 287292.
  • Farag NH, Moore WE, Lovallo WR, Mills PJ, Khandrika S, Eichner JE. 2008. Hypothalamic-pituitary-adrenal axis function: relative contributions of perceived stress and obesity in women. J Womens Health (Larchmt) 17: 16471655.
  • Felinski EA, Antonetti DA. 2005. Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy. Curr Eye Res 30: 949957.
  • Flammer JR, Rogatsky I. 2011. Minireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms. Mol Endocrinol 25: 10751086.
  • Friis M, Martin-Bertelsen T, Friis-Hansen L, Winther O, Henao R, MS SR, Qvortrup K. 2011. Gene expression of the endolymphatic sac. Acta Otolaryngol 131: 12571263.
  • Furuta T, Teranishi M, Uchida Y, Nishio N, Kato K, Otake H, Yoshida T, Tagaya M, Suzuki H, Sugiura M, Sone M, Hiramatsu M, Sugiura S, Ando F, Shimokata H, Nakashima T. 2011. Association of interleukin-1 gene polymorphisms with sudden sensorineural hearing loss and Meniere's disease. Int J Immunogenet 38: 249254.
  • Garcia-Berrocal JR, Ramirez-Camacho R. 2002. Sudden sensorineural hearing loss: supporting the immunologic theory. Ann Otol Rhinol Laryngol 111: 989997.
  • Garcia-Berrocal JR, Ramirez-Camacho R, Millan I, Gorriz C, Trinidad A, Arellano B, Lobo D. 2003. Sudden presentation of immune-mediated inner ear disease: characterization and acceptance of a cochleovestibular dysfunction. J Laryngol Otol 117: 775779.
  • Garduno-Anaya MA, Couthino de Toledo H, Hinojosa-Gonzalez R, Pane-Pianese C, Rios-Castaneda LC. 2005. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 133: 285294.
  • George DL, Pradhan S. 2009. Idiopathic sensorineural hearing disorders in adults—a pragmatic approach. Nat Rev Rheumatol 5: 505512.
  • Gross KL, Lu NZ, Cidlowski JA. 2009. Molecular mechanisms regulating glucocorticoid sensitivity and resistance. Mol Cell Endocrinol 300: 716.
  • Guimaraes P, Frisina ST, Mapes F, Tadros SF, Frisina DR, Frisina RD. 2006. Progestin negatively affects hearing in aged women. Proc Natl Acad Sci USA 103: 1424614249.
  • Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. 2007. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 117: 315.
  • Henkin RI, Daly RL. 1968. Auditory detection and perception in normal man and in patients with adrenal cortical insufficiency: effect of adrenal cortical steroids. J Clin Invest 47: 12691280.
  • Henley DE, Lightman SL. 2011. New insights into corticosteroid-binding globulin and glucocorticoid delivery. Neuroscience 180: 18.
  • Herman JP, Cullinan WE. 1997. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20: 7884.
  • Hervier B, Bordure P, Audrain M, Calais C, Masseau A, Hamidou M. 2010. Systematic screening for nonspecific autoantibodies in idiopathic sensorineural hearing loss: no association with steroid response. Otol Neurotol 31: 687690.
  • Hilger JA, Goltz NF. 1951. Some aspects of inner ear therapy. Laryngoscope 61: 695717.
  • Hutchison KA, Scherrer LC, Czar MJ, Stancato LF, Chow YH, Jove R, Pratt WB. 1993. Regulation of glucocorticoid receptor function through assembly of a receptor-heat shock protein complex. Ann NY Acad Sci 684: 3548.
  • Ishiyama G, Lopez IA, Beltran-Parrazal L, Ishiyama A. 2010. Immunohistochemical localization and mRNA expression of aquaporins in the macula utriculi of patients with Meniere's disease and acoustic neuroma. Cell Tissue Res 340: 407419.
  • Iversen PO, Nicolaysen A, Kvernebo K, Benestad HB, Nicolaysen G. 1999. Human cytokines modulate arterial vascular tone via endothelial receptors. Pflugers Arch 439: 93100.
  • Johansson-Haque K, Palanichamy E, Okret S. 2008. Stimulation of MAPK-phosphatase 1 gene expression by glucocorticoids occurs through a tethering mechanism involving C/EBP. J Mol Endocrinol 41: 239249.
  • Kakehata S, Sasaki A, Futai K, Kitani R, Shinkawa H. 2011. Daily short-term intratympanic dexamethasone treatment alone as an initial or salvage treatment for idiopathic sudden sensorineural hearing loss. Audiol Neurootol 16: 191197.
  • Kalin MF, Zumoff B. 1990. Sex hormones and coronary disease: a review of the clinical studies. Steroids 55: 330352.
  • Kanzaki J, Kanzaki S, Ogawa K. 2009. Long-term prognosis of steroid-dependent sensorineural hearing loss. Audiol Neurootol 14: 2634.
  • Kariya S, Cureoglu S, Fukushima H, Nomiya S, Nomiya R, Schachern PA, Nishizaki K, Paparella MM. 2009. Vascular findings in the stria vascularis of patients with unilateral or bilateral Meniere's disease: a histopathologic temporal bone study. Otol Neurotol 30: 10061012.
  • Kassel O, Herrlich P. 2007. Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol Cell Endocrinol 275: 1329.
  • Kastanioudakis I, Ziavra N, Voulgari PV, Exarchakos G, Skevas A, Drosos AA. 2002. Ear involvement in systemic lupus erythematosus patients: a comparative study. J Laryngol Otol 116: 103107.
  • Keithley EM, Chen MC, Linthicum F. 1998. Clinical diagnoses associated with histologic findings of fibrotic tissue and new bone in the inner ear. Laryngoscope 108: 8791.
  • Keles E, Godekmerdan A, Kalidag T, Kaygusuz I, Yalcin S, Cengiz Alpay H, Aral M. 2004. Meniere's disease and allergy: allergens and cytokines. J Laryngol Otol 118: 688693.
  • Kim SH, Kim KX, Raveendran NN, Wu T, Pondugula SR, Marcus DC. 2009. Regulation of ENaC-mediated sodium transport by glucocorticoids in Reissner's membrane epithelium. Am J Physiol Cell Physiol 296: C544C557.
  • Kitahara T, Doi K, Maekawa C, Kizawa K, Horii A, Kubo T, Kiyama H. 2008. Meniere's attacks occur in the inner ear with excessive vasopressin type-2 receptors. J Neuroendocrinol 20: 12951300.
  • Kitahara T, Maekawa C, Kizawa K, Horii A, Doi K. 2009. Plasma vasopressin and V2 receptor in the endolymphatic sac in patients with delayed endolymphatic hydrops. Otol Neurotol 30: 812819.
  • Klein RS. 2000. Comparing the attitudes of surgeons with those of infectious disease specialists regarding antibiotic treatment and prophylaxis of abdominal surgical infections. Surg Infect (Larchmt) 1: 287288; author reply 288.
  • Lamm K, Arnold W. 1999. How useful is corticosteroid treatment in cochlear disorders. Otorhinolaryngol Nova 9: 203216.
  • Larsson CA, Gullberg B, Rastam L, Lindblad U. 2009. Salivary cortisol differs with age and sex and shows inverse associations with WHR in Swedish women: a cross-sectional study. BMC Endocr Disord 9: 16.
  • Lazarini PR, Camargo AC. 2006. Idiopathic sudden sensorineural hearing loss: etiopathogenic aspects. Braz J Otorhinolaryngol 72: 554561.
  • Lee JH, Marcus DC. 2002. Nongenomic effects of corticosteroids on ion transport by stria vascularis. Audiol Neurootol 7: 100106.
  • Li P, Zeng XL, Ye J, Yang QT, Zhang GH, Li Y. 2011. Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study. Audiol Neurootol 16: 198202.
  • Lin DW, Trune DR. 1997. Breakdown of stria vascularis blood-labyrinth barrier in C3H/lpr autoimmune disease mice. Otolaryngol Head Neck Surg 117: 530534.
  • Loveman DM, de Comarmond C, Cepero R, Baldwin DM. 2004. Autoimmune sensorineural hearing loss: clinical course and treatment outcome. Semin Arthritis Rheum 34: 538543.
  • Lowenberg M, Stahn C, Hommes DW, Buttgereit F. 2008. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids 73: 10251029.
  • Maeda Y, Fukushima K, Hirai M, Kariya S, Smith RJ, Nishizaki K. 2010. Microarray analysis of the effect of dexamethasone on murine cochlear explants. Acta Otolaryngol 130: 13291334.
  • Mallur PS, Weisstuch A, Pfister M, Mhatre AN, Lalwani AK. 2010. Aquaporin-2 and -4: single nucleotide polymorphisms in Meniere's disease patients. Audiol Med 8: 1823.
  • Marcus BC, Hynes KL, Gewertz BL. 1997. Loss of endothelial barrier function requires neutrophil adhesion. Surgery 122: 420426; discussion 426–427.
  • Mathews J, Kumar BN. 2003. Autoimmune sensorineural hearing loss. Clin Otolaryngol Allied Sci 28: 479488.
  • Mattox DE. 1980. Medical management of sudden hearing loss. Otolaryngol Head Neck Surg 88: 111113.
  • Mattox DE, Simmons FB. 1977. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 86: 463480.
  • McCabe BF. 1979. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 88: 585589.
  • McEwen BS. 2000. Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity. Neurochem Res 25: 12191231.
  • Meltser I, Tahera Y, Canlon B. 2009. Glucocorticoid receptor and mitogen-activated protein kinase activity after restraint stress and acoustic trauma. J Neurotrauma 26: 18351845.
  • Merchant SN, Adams JC, Nadol JB, Jr. 2005a. Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss. Otol Neurotol 26: 151160.
  • Merchant SN, Adams JC, Nadol JB, Jr. 2005b. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 26: 7481.
  • Merchant SN, Durand ML, Adams JC. 2008. Sudden deafness: is it viral? ORL J Otorhinolaryngol Relat Spec 70: 5260; discussion 60–52.
  • Morita S, Suzuki M, Iizuka K. 2010. A comparison of the short-term outcome in patients with acute low-tone sensorineural hearing loss. ORL J Otorhinolaryngol Relat Spec 72: 295299.
  • Murphy D, Daniel SJ. 2011. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model. Otolaryngol Head Neck Surg 145: 452457.
  • Nacci A, Dallan I, Monzani F, Dardano A, Migliorini P, Riente L, Ursino F, Fattori B. 2010. Elevated antithyroid peroxidase and antinuclear autoantibody titers in Meniere's disease patients: more than a chance association? Audiol Neurootol 15: 16.
  • Nadel DM. 1996. The use of systemic steroids in otolaryngology. Ear Nose Throat J 75: 502505, 509–510, 511–502 passim.
  • Nadol JB, McKenna MJ. 1987. Histopathology of Meniere's disease and otosclerosis. In: Veldman JE, editor. Immunobiology, histopathology, tumor immunology in otorhinolaryngology. Amsterdam: Kugler Publications. p 165184.
  • Naganawa S, Koshikawa T, Fukatsu H, Ishigaki T, Nakashima T, Ichinose N. 2002. Contrast-enhanced MR imaging of the endolymphatic sac in patients with sudden hearing loss. Eur Radiol 12: 11211126.
  • Nakagawa T, Sakamoto T, Hiraumi H, Kikkawa YS, Yamamoto N, Hamaguchi K, Ono K, Yamamoto M, Tabata Y, Teramukai S, Tanaka S, Tada H, Onodera R, Yonezawa A, Inui K, Ito J. 2010. Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial. BMC Med 8: 76.
  • Nieuwdorp M, Meuwese MC, Mooij HL, van Lieshout MH, Hayden A, Levi M, Meijers JC, Ince C, Kastelein JJ, Vink H, Stroes ES. 2009. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis 202: 296303.
  • Nosrati-Zarenoe R, Arlinger S, Hultcrantz E. 2007. Idiopathic sudden sensorineural hearing loss: results drawn from the Swedish national database. Acta Otolaryngol 127: 11681175.
  • Ottaviani F, Cadoni G, Marinelli L, Fetoni AR, de Santis A, Romito A, Vulpiani P, Manna R. 1999. Anti-endothelial autoantibodies in patients with sudden hearing loss. Laryngoscope 109: 10841087.
  • Paparella MM, Djalilian HR. 2002. Etiology, pathophysiology of symptoms, and pathogenesis of Meniere's disease. Otolaryngol Clin North Am 35: 529545, vi.
  • Pappas DG, Banyas JB. 1991. A newly recognized etiology of Meniere's syndrome. A preliminary report. Acta Otolaryngol Suppl 485: 104107.
  • Pathak S, Goldofsky E, Vivas EX, Bonagura VR, Vambutas A. 2011. IL-1beta is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease. J Immunol 186: 18701879.
  • Peitersen E, Carlson BH. 1966. Hearing impairment as the initial sign of polyarteritis nodosa. Acta Otolaryngol 61: 189195.
  • Phillips JS, Westerberg B. 2011. Intratympanic steroids for Meniere's disease or syndrome. Cochrane Database Syst Rev: CD008514.
  • Piccirillo JF. 2011. Steroids for idiopathic sudden sensorineural hearing loss: some questions answered, others remain. JAMA 305: 21142115.
  • Porter RJ, Gallagher P, O'Brien JT. 2007. Effects of rapid tryptophan depletion on salivary cortisol in older people recovered from depression, and the healthy elderly. J Psychopharmacol 21: 7175.
  • Price K, Zhu X, Guimaraes PF, Vasilyeva ON, Frisina RD. 2009. Hormone replacement therapy diminishes hearing in peri-menopausal mice. Hear Res 252: 2936.
  • Psifidis AD, Psillas GK, Daniilidis J. 2006. Sudden sensorineural hearing loss: long-term follow-up results. Otolaryngol Head Neck Surg 134: 809815.
  • Psillas G, Kekes G, Giavroglou K, Daniilidis J. 2005. Digital subtraction angiography abnormalities in sudden unilateral profound hearing loss. Acta Otolaryngol 125: 840847.
  • Pyykko I, Zou J, Poe D, Nakashima T, Naganawa S. 2010. Magnetic resonance imaging of the inner ear in Meniere's disease. Otolaryngol Clin North Am 43: 10591080.
  • Qvortrup K, Rostgaard J, Holstein-Rathlou NH. 1996. The inner ear produces a natriuretic hormone. Am J Physiol 270: F10731077.
  • Rarey KE, Curtis LM, ten Cate WJ. 1993. Tissue specific levels of glucocorticoid receptor within the rat inner ear. Hear Res 64: 205210.
  • Rauch SD. 2008. Clinical practice. Idiopathic sudden sensorineural hearing loss. N Engl J Med 359: 833840.
  • Rauch SD. 2010. Clinical hints and precipitating factors in patients suffering from Meniere's disease. Otolaryngol Clin North Am 43: 10111017.
  • Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, Goebel JA, Hammerschlag PE, Harris JP, Isaacson B, Lee D, Linstrom CJ, Parnes LS, Shi H, Slattery WH, Telian SA, Vrabec JT, Reda DJ. 2011. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA 305: 20712079.
  • Raymundo IT, Bahmad F, Jr., Barros Filho J, Pinheiro TG, Maia NA, Oliveira CA. 2010. Intratympanic methylprednisolone as rescue therapy in sudden sensorineural hearing loss. Braz J Otorhinolaryngol 76: 499509.
  • Reul JM, de Kloet ER. 1985. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117: 25052511.
  • Roverano S, Cassano G, Paira S, Chiavarini J, Graf C, Rico L, Heredia C. 2006. Asymptomatic sensorineural hearing loss in patients with systemic lupus erythematosus. J Clin Rheumatol 12: 217220.
  • Ruckenstein MJ, Milburn M, Hu L. 1999. Strial dysfunction in the MRL-Fas mouse. Otolaryngol Head Neck Surg 121: 452456.
  • Salt AN, Plontke SK. 2010. Endolymphatic hydrops: pathophysiology and experimental models. Otolaryngol Clin North Am 43: 971983.
  • Sapolsky RM, Krey LC, McEwen BS. 1984. Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc Natl Acad Sci USA 81: 61746177.
  • Savastano M, Giacomelli L, Marioni G. 2007. Non-specific immunological determinations in Meniere's disease: any role in clinical practice? Eur Arch Otorhinolaryngol 264: 1519.
  • Sawada S, Takeda T, Saito H. 1997. Antidiuretic hormone and psychosomatic aspects in Meniere's disease. Acta Otolaryngol Suppl 528: 109112.
  • Schimmer BP, Parker KL. 2006. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman's the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill. p 15871612.
  • Seckl JR, Meaney MJ. 2004. Glucocorticoid programming. Ann NY Acad Sci 1032: 6384.
  • Seggas I, Koltsidopoulos P, Bibas A, Tzonou A, Sismanis A. 2011. Intratympanic steroid therapy for sudden hearing loss: a review of the literature. Otol Neurotol 32: 2935.
  • Shearer AE, DeLuca AP, Hildebrand MS, Taylor KR, Gurrola J, II, Scherer S, Scheetz TE, Smith RJ. 2010. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA 107: 2110421109.
  • Shimazaki T, Ichimiya I, Suzuki M, Mogi G. 2002. Localization of glucocorticoid receptors in the murine inner ear. Ann Otol Rhinol Laryngol 111: 11331138.
  • Shin JJ, Randolph GW, Rauch SD. 2010. Evidence-based medicine in otolaryngology, part 1: the multiple faces of evidence-based medicine. Otolaryngol Head Neck Surg 142: 637646.
  • Shin JJ, Rauch SD, Wasserman J, Coblens O, Randolph GW. 2011. Evidence-based medicine in otolaryngology, part 2: the current state of affairs. Otolaryngol Head Neck Surg 144: 331337.
  • Smets P, Meyer E, Maddens B, Daminet S. 2010. Cushing's syndrome, glucocorticoids and the kidney. Gen Comp Endocrinol 169: 110.
  • Smith JL. 1970. Cogan's syndrome. Laryngoscope 80: 121132.
  • Spear SA, Schwartz SR. 2011. Intratympanic steroids for sudden sensorineural hearing loss: a systematic review. Otolaryngol Head Neck Surg 145: 534543.
  • Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, Brown SR, Fife TD, Ford P, Ganiats TG, Hollingsworth DB, Lewandowski CA, Montano JJ, Saunders JE, Tucci DL, Valente M, Warren BE, Yaremchuk KL, Robertson PJ. 2012. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 146: S1S35.
  • Stephens SD, Luxon L, Hinchcliffe R. 1982. Immunological disorders and auditory lesions. Audiology 21: 128148.
  • Sugiura M, Naganawa S, Teranishi M, Nakashima T. 2006. Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging findings in patients with sudden sensorineural hearing loss. Laryngoscope 116: 14511454.
  • Sugiura M, Nakashima T, Naganawa S, Otake Y, Mukaida T, Sone M, Sato E. 2005. Sudden sensorineural hearing loss associated with inner ear anomaly. Otol Neurotol 26: 241246.
  • Suzuki H, Mori T, Hashida K, Shibata M, Nguyen KH, Wakasugi T, Hohchi N. 2011a. Prediction model for hearing outcome in patients with idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 268: 497500.
  • Suzuki H, Teranishi M, Sone M, Yamazaki M, Naganawa S, Nakashima T. 2011b. Contrast enhancement of the inner ear after intravenous administration of a standard or double dose of gadolinium contrast agents. Acta Otolaryngol 131: 10251031.
  • Tagaya M, Yamazaki M, Teranishi M, Naganawa S, Yoshida T, Otake H, Nakata S, Sone M, Nakashima T. 2011. Endolymphatic hydrops and blood-labyrinth barrier in Meniere's disease. Acta Otolaryngol 131: 474479.
  • Tahera Y, Meltser I, Johansson P, Bian Z, Stierna P, Hansson AC, Canlon B. 2006a. NF-kappaB mediated glucocorticoid response in the inner ear after acoustic trauma. J Neurosci Res 83: 10661076.
  • Tahera Y, Meltser I, Johansson P, Hansson AC, Canlon B. 2006b. Glucocorticoid receptor and nuclear factor-kappa B interactions in restraint stress-mediated protection against acoustic trauma. Endocrinology 147: 44304437.
  • Tahera Y, Meltser I, Johansson P, Salman H, Canlon B. 2007. Sound conditioning protects hearing by activating the hypothalamic-pituitary-adrenal axis. Neurobiol Dis 25: 189197.
  • Taylor KR, Gallo RL. 2006. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 20: 922.
  • Teggi R, Zagato L, Delli Carpini S, Messaggio E, Casamassima N, Lanzani C, Manunta P, Bussi M. 2010. Endogenous ouabain in Meniere's disease. Otol Neurotol 31: 153156.
  • ten Cate WJ, Curtis LM, Small GM, Rarey KE. 1993. Localization of glucocorticoid receptors and glucocorticoid receptor mRNAs in the rat cochlea. Laryngoscope 103: 865871.
  • Thirlwall AS, Kundu S. 2006. Diuretics for Meniere's disease or syndrome. Cochrane Database Syst Rev 3: CD003599.
  • Topak M, Sahin-Yilmaz A, Ozdoganoglu T, Yilmaz HB, Ozbay M, Kulekci M. 2009. Intratympanic methylprednisolone injections for subjective tinnitus. J Laryngol Otol 123: 12211225.
  • Trune D, Delaney K, Hausman F, Kempton B, MacArthur C, Choi D. 2012. Transtympanically delivered steroids impact thousands of inner ear genes over conventional systemic delivery. Presented at Meeting of the Association Research Otolaryngology. San Diego, CA.
  • Trune DR. 1997. Cochlear immunoglobulin in the C3H/lpr mouse model for autoimmune hearing loss. Otolaryngol Head Neck Surg 117: 504508.
  • Trune DR. 2001. Mouse models for immunologic diseases of the auditory system. In: Willott JF, editor. Handbook of mouse auditory research: from behavior to molecular biology. Boca Raton: CRC Press. p 505531.
  • Trune DR. 2010. Ion homeostasis in the ear: mechanisms, maladies, and management. Curr Opin Otolaryngol Head Neck Surg 18: 413419.
  • Trune DR, Hausman F, Kempton B. 2011a. Cochlear ion homeostasis mechanisms are suppressed in autoimmune inner ear disease and restored by glucocorticoid treatment. Presented at Meeting of the Association Research Otolaryngology. Baltimore, MD.
  • Trune DR, Kempton JB. 2001. Aldosterone and prednisolone control of cochlear function in MRL/MpJ-Fas(lpr) autoimmune mice. Hear Res 155: 920.
  • Trune DR, Kempton JB. 2010. Low dose combination steroids control autoimmune mouse hearing loss. J Neuroimmunol 229: 140145.
  • Trune DR, Kempton JB, Gross ND. 2006. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hear Res 212: 2232.
  • Trune DR, Kempton JB, Kessi M. 2000. Aldosterone (mineralocorticoid) equivalent to prednisolone (glucocorticoid) in reversing hearing loss in MRL/MpJ-Fas1pr autoimmune mice. Laryngoscope 110: 19021906.
  • Trune DR, Larrain BE, Hausman FA, Kempton JB, MacArthur CJ. 2011b. Simultaneous measurement of multiple ear proteins with multiplex ELISA assays. Hear Res 275: 17.
  • Underwood JL, Murphy CG, Chen J, Franse-Carman L, Wood I, Epstein DL, Alvarado JA. 1999. Glucocorticoids regulate transendothelial fluid flow resistance and formation of intercellular junctions. Am J Physiol 277: C330C342.
  • Vambutas A, DeVoti J, Goldofsky E, Gordon M, Lesser M, Bonagura V. 2009. Alternate splicing of interleukin-1 receptor type II (IL1R2) in vitro correlates with clinical glucocorticoid responsiveness in patients with AIED. PLoS One 4: e5293.
  • Van de Water TA, Lomax AJ, Bijl HP, de Jong ME, Schilstra C, Hug EB, Langendijk JA. 2011. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. Int J Radiat Oncol Biol Phys 79: 12161224.
  • Vlastarakos PV, Papacharalampous G, Maragoudakis P, Kampessis G, Maroudias N, Candiloros D, Nikolopoulos TP. Are intra-tympanically administered steroids effective in patients with sudden deafness? Implications for current clinical practice. Eur Arch Otorhinolaryngol 269: 363380.
  • Vrabec JT. 2010. Genetic investigations of Meniere's disease. Otolaryngol Clin North Am 43: 11211132.
  • Walker BR, Andrew R. 2006. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease. Ann NY Acad Sci 1083: 165184.
  • Walker JJ, Terry JR, Tsaneva-Atanasova K, Armstrong SP, McArdle CA, Lightman SL. 2010. Encoding and decoding mechanisms of pulsatile hormone secretion. J Neuroendocrinol 22: 12261238.
  • Wei BP, Mubiru S, O'Leary S. 2006. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev: CD003998.
  • Witsell DL, Rauch SD, Tucci DL, Telian SA, Roland PS, Nguyen-Huynh AT, Schulz K. 2011. The Otology Data Collection project: report from the CHEER network. Otolaryngol Head Neck Surg 145: 572580.
  • Yehuda R, Golier JA, Tischler L, Stavitsky K, Harvey PD. 2005. Learning and memory in aging combat veterans with PTSD. J Clin Exp Neuropsychol 27: 504515.
  • Yoshida T, Sugiura M, Naganawa S, Teranishi M, Nakata S, Nakashima T. 2008. Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging findings and prognosis in sudden sensorineural hearing loss. Laryngoscope 118: 14331437.
  • Yue WL, Li P, Qi PY, Li HJ, Zhou H. 2003. Role of low-molecular-weight heparins in the treatment of sudden hearing loss. Am J Otolaryngol 24: 328333.
  • Yukawa H, Shen J, Harada N, Cho-Tamaoka H, Yamashita T. 2005. Acute effects of glucocorticoids on ATP-induced Ca2+ mobilization and nitric oxide production in cochlear spiral ganglion neurons. Neuroscience 130: 485496.